Menu

• Ask a Health Expert about FIBRIN DEGRADATION PRODUCTS INCREASED
• Post Your Side Effect related to FIBRIN DEGRADATION PRODUCTS INCREASED
• FIBRIN DEGRADATION PRODUCTS INCREASED and FDA Warnings
• FIBRIN DEGRADATION PRODUCTS INCREASED in Patients Wiki
• Report FIBRIN DEGRADATION PRODUCTS INCREASED in Drug Side Effect Survey

FIBRIN DEGRADATION PRODUCTS INCREASED side effect

What is FIBRIN DEGRADATION PRODUCTS INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Mylotarg Side Effects Report #5372365-8
Physician from JAPAN reported MYLOTARG problem on June 20, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fibrin degradation products increased, lung infection, neutropenia, obliterative bronchiolitis, sepsis, . MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.

Mylotarg Side Effects Report #5316591-2
MYLOTARG problem was reported by a Physician from JAPAN on Apr 27, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fibrin degradation products increased, lung infection, obliterative bronchiolitis, sepsis, . MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.

Mylotarg Side Effects Report #5257031-1
Physician from JAPAN reported MYLOTARG problem on Feb 24, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fibrin degradation products increased, lung infection, obliterative bronchiolitis, sepsis, . MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.

Sprintec Side Effects Report #5581209-0
SPRINTEC problem was reported by a Physician from POLAND on Dec 17, 2007. Female patient, 31 years of age, was diagnosed with oral contraception and was treated with SPRINTEC. After drug was administered, patient experienced the following problems/side effects: blood homocysteine increased, cerebral ischaemia, fibrin degradation products increased, loss of consciousness, . SPRINTEC dosage: unknown. Patient was hospitalized. Patient recovered.


Mylotarg Side Effects Report #5507775-9
Physician from JAPAN reported MYLOTARG problem on Oct 30, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, pneumonia, sepsis, white blood cell count decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5315902-1
MYLOTARG problem was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, sepsis, white blood cell count decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5263982-4
Physician from JAPAN reported MYLOTARG problem on Mar 06, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, sepsis, . MYLOTARG dosage: unknown. During the same period patient was treated with LIPOVAS, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, ENOCITABINE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.